Quadrant Biosciences gets FDA approval for saliva-based COVID-19 test
Quadrant Biosciences said late Wednesday it received an emergency approval from the Food and Drug Administration for a saliva-based COVID-19 test. The privately held Syracuse, N.Y.-based company developed the test along with State University of New York's Upstate Medical University. Called the "Clarifi COVID-19" test, the diagnostic collects saliva with a swab and uses reagents to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19. The test is available for bulk purchases immediately by clinical laboratories for use at healthcare facilities, Quadrant said.
-Wallace Witkowski; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
September 23, 2020 17:28 ET (21:28 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.